Clinical Trials Logo

Obesity clinical trials

View clinical trials related to Obesity.

Filter by:

NCT ID: NCT03776552 Not yet recruiting - Obesity Clinical Trials

Effect of Gradual Versus Rapid Weight Loss

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

This randomized controlled trial aims to compare the 4-month and 1-year effects of initial rapid weight loss and gradual weight loss (GWL), by using a low energy diet (LED) -program (intervention) or a standard GWL-program (control), respectively.

NCT ID: NCT03776513 Recruiting - Pediatric Obesity Clinical Trials

Neuro-cognitive Impact of Juvenile Obesity

Start date: December 12, 2018
Phase: N/A
Study type: Interventional

Recent studies indicate that obese teenagers exhibit memory disturbances. Adolescence represents a crucial period in the development of the hippocampus and the amygdala, necessary for the implementation of memory and emotional functions for the rest of life. Disturbances of the interaction between amygdala and hippocampus during adolescence have been associated with the development of neuropsychiatric disorders. However, the impact of juvenile obesity on functional amygdala-hippocampus connectivity has not been evaluated yet. The main objective of this study is to compare the emotional memory performance and the level of functional connectivity between the hippocampus and the amygdala during the realization of an emotional associative memory task, in obese and control adolescents.

NCT ID: NCT03774511 Completed - Obesity Clinical Trials

Effects of Exercise on Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled Trial

Start date: July 9, 2017
Phase: N/A
Study type: Interventional

background: Obesity, diabetes mellitus type II and fatty liver disease combining with low levels of physical activity are prominent health risks for mortality and morbidity. More than 1/3 of the current population is suffering from obesity with a significant proportion to medical complications which can negatively influence their quality of life. These complications comprise alterations of the metabolism of glucose and fat, insulin resistance and diabetes mellitus. Objectives The purpose of this study was to compare between high intensity interval exercise and moderate intensity continuous on diabetic obese patients with NAFLD. Methods: thirty patients were randomly classified into two groups. Group I included fifteen patients, received medical treatment with a program of high-intensity interval exercise 3 times/week for eight weeks (HII group) and group II included fifteen patients, received moderate intensity continuous exercise3 times/week for eight weeks (MIC group). All participants were evaluated for the IHTG, visceral lipids, and CLDQ before the intervention (pre-program) and at the end of eight weeks of intervention (post-program) by the examiner who will be blinded concerning the group to which each patient will be appointed.

NCT ID: NCT03774381 Recruiting - Obesity Clinical Trials

Effect of Bifidobacterium Breve B-3 on Body Fat in Obese Adults

Start date: September 1, 2018
Phase: N/A
Study type: Interventional

Comparison of a randomized, double-blind, and control-group study for the effect of oral ingestion of Bifidobacterium breve B-3 on body fat reduction in obese adults

NCT ID: NCT03774095 Recruiting - Obesity Clinical Trials

Effect of Dietary Oils as G-protein-coupled Receptor Agonists on Glucose Tolerance

Start date: June 11, 2018
Phase: N/A
Study type: Interventional

Agonistic activation of fat metabolite responsive G-protein-coupled receptors (GPCR) has been linked to improved glucose metabolism through increased glucose-stimulated-insulin-secreting (GSIS) and incretin release, improved insulin sensitivity and reduced low grade inflammation. In vitro studies have demonstrated that pinolenic acid (20% of pine nut oil) is a potent dual agonist of two GPCRs: free fatty acid receptor-1 (FFA1, formerly GPR40) and free fatty acid receptor-4 (FFA4, formerly GPR120). Moreover, pinolenic acid was able to improve glucose tolerance in mice. G-protein-coupled receptor-119 (GPR119) is known to be activated by the monoacylglycerol: 2-oleoylglycerol (2OG), which is a glycerol molecule attached to oleic acid in the second position. Olive oil contains 61-80% oleic acid, and under digestion 2OG is produced. 2OG has been shown to stimulate GLP-1 release in humans and interestingly, it has recently been suggest that simultaneous activation of GPR119 and FFA1 acts in synergy and enhances enteroendocrine GLP-1 secretion more than the summarized individual agonistic activation. However, this remains to be evaluated in humans. The investigators hypothesize that a combination of pinolenic acid and 2OG administered in delayed release capsules will act in synergy and enhance 1) GLP-1 secretion by stimulating FFA1/FFA4 and GPR119 on enteroendocrine cells causing improved GSIS and increased satiety and 2) enhance GSIS by directly stimulating FFA1 and GPR119 on beta-cells. Study aim: To investigate the acute effects of pinolenic acid combined with 2OG (olive oil) versus pinolenic acid alone on changes in glucose tolerance, insulin, GLP-1, GIP and ghrelin secretion, appetite and gastrointestinal tolerability in overweight and obese healthy humans.

NCT ID: NCT03773250 Recruiting - Clinical trials for Overweight and Obesity

A FAMILY Program for Childhood Overweight and Obesity

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

Childhood overweight and obesity is a health problem with lifelong implications related to diabetes, hypertension, cardiovascular disease, psychological disorders as well as other chronic conditions.

NCT ID: NCT03772886 Not yet recruiting - Obesity Clinical Trials

Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball

Start date: January 15, 2019
Phase: N/A
Study type: Interventional

This study aims to determine if using the peanut ball during the active phase of labor reduces the cesarean delivery rate when compared to normal intrapartum management (no peanut ball) in the obese patient population.

NCT ID: NCT03771690 Completed - Obesity Clinical Trials

Individual Variability of Appetite Responses to a Standardised Meal

Start date: January 11, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to examine the interindividual variability of subjective and hormonal appetite responses to a standardised meal in healthy men and explore any moderating influence of the fat mass and obesity associated gene (FTO). Participants homozygous for the obesity risk A allele (AA) or low risk T allele (TT) of FTO rs9939609 will complete two fasted control and two standardised meal (5025 kJ energy, 47% carbohydrate, 9% protein, 44% fat) conditions in randomised sequences. Ratings of perceived appetite and venous blood samples will be taken before and after the interventions. Interindividual differences in appetite responses and the potential moderating influence of the FTO gene will be examined using bivariate correlations and linear mixed modelling.

NCT ID: NCT03771261 Recruiting - Obesity Clinical Trials

Balanced (Egg) Protein During Obesity Reduction: Differential Responses of Insulin Resistance by Race

Start date: June 15, 2018
Phase: N/A
Study type: Interventional

The purpose of the trial is to assess the effects of combining regular, generous intakes of high quality protein (with substantial amounts provided from whole eggs and egg whites) with calorie restriction on insulin resistance and weight loss (along with function, body composition, racial disparities, and a number of secondary outcomes) in black and white older adults with prediabetes who are participating in a 4-month intervention. The investigators will compare these effects to the same outcomes with a control group consuming a traditional control regimen of calorie restriction over the same duration.

NCT ID: NCT03768245 Completed - Obesity Clinical Trials

School-Based Program On Metabolic Disease

Start date: July 1, 2016
Phase: N/A
Study type: Interventional

Mexico occupies the first place worldwide in childhood obesity. Its urban and indigenous communities present different levels of westernization which have triggered different epidemiological diseases. This study aims to treat and prevent obesity and related diseases. A school-based multi-component intervention program is developed in three ethnic groups with varying levels of westernization: Mestizos, Seris and Yaquis. Measurements are obtained to evaluate obesity, cardiovascular, diabetes risk, hepatic and renal function, and physical fitness. The intervention consists on Physical Activity (PA), Health Education (HE) and Nutrition (NP) programs carried out in six urban (Mestizo ethnic group) and indigenous schools (Seri and Yaqui ethnic groups). A total of 800 participants were part of the PA and HE programs (Education Arm), and 117 of them were also part of the NP program (Nutrition Arm). Measurement differences, after and before treatments are used to assess the intervention effect by age, sex, ethnicity, nutritional status, and treatments. Expanded access is not applicable to this study. The Government's Secretary of Education does not allow developing a plan to share individual data of participants.